MedKoo Cat#: 571025 | Name: Promazine

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Promazine is a phenothiazine analogue of imipramine with actions similar to chlorpromazine but with less antipsychotic activity. It is primarily used in short-term treatment of disturbed behavior and as an antiemetic. It has predominantly anticholinergic side effects.

Chemical Structure

Promazine
Promazine
CAS#58-40-2

Theoretical Analysis

MedKoo Cat#: 571025

Name: Promazine

CAS#: 58-40-2

Chemical Formula: C17H20N2S

Exact Mass: 284.1347

Molecular Weight: 284.42

Elemental Analysis: C, 71.79; H, 7.09; N, 9.85; S, 11.27

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
53-60-1 (HCl) 58-40-2 (free base)
Synonym
Promazine; Sinophenin; Tomil; NSC 31447; Esparin; Sparine
IUPAC/Chemical Name
10H-Phenothiazine-10-propanamine, N,N-dimethyl- (9CI)
InChi Key
ZGUGWUXLJSTTMA-UHFFFAOYSA-N
InChi Code
InChI=1S/C17H20N2S/c1-18(2)12-7-13-19-14-8-3-5-10-16(14)20-17-11-6-4-9-15(17)19/h3-6,8-11H,7,12-13H2,1-2H3
SMILES Code
CN(C)CCCN1C2=C(C=CC=C2)SC3=CC=CC=C13
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 284.42 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: La Rocca R, Ferrari-Toninelli G, Patanè S. Widened QRS interval and left ventricular systolic depression after propafenone and promazine exposure. Int J Cardiol. 2014 Nov 15;177(1):57-60. doi: 10.1016/j.ijcard.2014.09.095. Epub 2014 Oct 11. PubMed PMID: 25499340. 2: Lasić D, Cvitanović MZ, Uglešić B, Višić V, Hlevnjak I. Exanthema medicamentosum as a side effect of promazine. Psychiatr Danub. 2011 Jun;23(2):194-7. PubMed PMID: 21685860. 3: Purohit AK, Balish MD, Leichty JJ, Roe A, Ward LM, Mitchell MO, Hsia SC. Antiviral activity and synthesis of quaternized promazine derivatives against HSV-1. Bioorg Med Chem Lett. 2012 Aug 15;22(16):5308-12. doi: 10.1016/j.bmcl.2012.06.031. Epub 2012 Jun 19. PubMed PMID: 22789428. 4: Dewey EA, Maylin GA, Ebel JG, Henion JD. The metabolism of promazine and acetylpromazine in the horse. Drug Metab Dispos. 1981 Jan-Feb;9(1):30-6. PubMed PMID: 6111428. 5: Syrek M, Wójcikowski J, Daniel W. Effect of carbamazepine on the pharmacokinetics of promazine. Pol J Pharmacol. 1996 Nov-Dec;48(6):601-8. PubMed PMID: 9112700. 6: Daniel W, Syrek M, Janczar L, Boksa J. The pharmacokinetics of promazine and its metabolites after acute and chronic administration to rats--a comparison with the pharmacokinetics of imipramine. Pol J Pharmacol. 1995 Mar-Apr;47(2):127-36. PubMed PMID: 8688885. 7: Kodavanti UP, Lockard VG, Mehendale HM. In vivo toxicity and pulmonary effects of promazine and chlorpromazine in rats. J Biochem Toxicol. 1990 Winter;5(4):245-51. PubMed PMID: 1965728. 8: Hu OY, Tang HS, Sheeng TY, Chen SC, Lee SK, Chung PH. Pharmacokinetics of promazine: I. Disposition in patients with acute viral hepatitis B. Biopharm Drug Dispos. 1990 Oct;11(7):557-68. PubMed PMID: 2265236. 9: Merville MP, Piette J, Lopez M, Decuyper J, van de Vorst A. Termination sites of the in vitro DNA synthesis on single-stranded DNA photosensitized by promazines. J Biol Chem. 1984 Dec 25;259(24):15069-77. PubMed PMID: 6239864. 10: Hu OY, Tang HS, Sheeng TY, Chen TC, Curry SH. Pharmacokinetics of promazine in patients with hepatic cirrhosis--correlation with a novel galactose single point method. J Pharm Sci. 1995 Jan;84(1):111-4. PubMed PMID: 7714731. 11: Koytchev R, Alken RG, Kirkov V, Neshev G, Vagaday M, Kunter U. [Absolute bioavailability of chlorpromazine, promazine and promethazine]. Arzneimittelforschung. 1994 Feb;44(2):121-5. German. PubMed PMID: 8147942. 12: Hu OY, Curry SH. Stability, human blood distribution and rat tissue localization of promazine and desmonomethylpromazine. Biopharm Drug Dispos. 1989 Nov-Dec;10(6):537-48. PubMed PMID: 2611355. 13: Wang Q, Liu L, Yang X, Wang K, Chen N, Zhou C, Luo B, Du S. Evaluation of medicine effects on the interaction of myoglobin and its aptamer or antibody using atomic force microscopy. Anal Chem. 2015 Feb 17;87(4):2242-8. doi: 10.1021/ac503885e. Epub 2015 Feb 4. PubMed PMID: 25615803. 14: Sweatt JD, Palmer GC, Palmer SJ, Jackson TG, Manian AA. Benzo [b]-promazines, chlorpromazine free radical and analino-N, N-dimethylpropylamine analogs influence rat striatal DA-adenylate cyclase and calmodulin-phosphodiesterase. Arch Int Pharmacodyn Ther. 1982 Jun;257(2):188-99. PubMed PMID: 6287952. 15: Syrek M, Wójcikowski J, Daniel WA. Promazine pharmacokinetics during concurrent treatment with tricyclic antidepressants. Pol J Pharmacol. 1997 Nov-Dec;49(6):453-62. PubMed PMID: 9566049. 16: Wójcikowski J, Pichard-Garcia L, Maurel P, Daniel WA. Contribution of human cytochrome p-450 isoforms to the metabolism of the simplest phenothiazine neuroleptic promazine. Br J Pharmacol. 2003 Apr;138(8):1465-74. PubMed PMID: 12721102; PubMed Central PMCID: PMC1573803. 17: Daniel WA, Syrek M, Wójcikowski J. The influence of selective serotonin reuptake inhibitors on the plasma and brain pharmacokinetics of the simplest phenothiazine neuroleptic promazine in the rat. Eur Neuropsychopharmacol. 1999 Jun;9(4):337-44. PubMed PMID: 10422895. 18: John E. Promazine and neonatal hyperbilirubinaemia. Med J Aust. 1975 Aug 30;2(9):342-4. PubMed PMID: 1237776. 19: Ensafi AA, Hasanpour F, Khayamian T. Simultaneous chemiluminescence determination of promazine and fluphenazine using support vector regression. Talanta. 2009 Jul 15;79(2):534-8. doi: 10.1016/j.talanta.2009.04.023. Epub 2009 Apr 19. PubMed PMID: 19559917. 20: Ruokolainen M, Gul T, Permentier H, Sikanen T, Kostiainen R, Kotiaho T. Comparison of TiO2 photocatalysis, electrochemically assisted Fenton reaction and direct electrochemistry for simulation of phase I metabolism reactions of drugs. Eur J Pharm Sci. 2016 Feb 15;83:36-44. doi: 10.1016/j.ejps.2015.12.012. Epub 2015 Dec 10. PubMed PMID: 26690045.